Simplex Trading
BDTX icon

Simplex Trading’s Black Diamond Therapeutics BDTX Stock Holding History

Simplex Trading’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,186
Closed -$6.39K – 9054
2025
Q2 		$5K Buy
+2,186
New +$4.21K ﹤0.01% 7709
2025
Q1 		– Sell
-1,326
Closed -$2.78K – 8530
2024
Q4 		$2K Sell
1,326
-19,473
-94% -$55.8K ﹤0.01% 7968
2024
Q3 		$90K Sell
20,799
-235
-1% -$1.28K ﹤0.01% 5332
2024
Q2 		$98K Buy
21,034
+13,542
+181% +$72.7K ﹤0.01% 5397
2024
Q1 		$37K Buy
7,492
+7,266
+3,215% +$29.3K ﹤0.01% 6545
2023
Q4 		$0 Buy
+226
New +$530 ﹤0.01% 8766
2023
Q3 		– Sell
-350
Closed -$1.29K – 8669
2023
Q2 		$1K Buy
+350
New +$715 ﹤0.01% 8571
2022
Q2 		– Sell
-2,202
Closed -$5.12K – 9948
2022
Q1 		$6K Buy
2,202
+66
+3% +$241 ﹤0.01% 9260
2021
Q4 		$11K Buy
2,136
+1,547
+263% +$10.8K ﹤0.01% 8919
2021
Q3 		$7K Sell
589
-100
-15% -$987 ﹤0.01% 9096
2021
Q2 		$8K Buy
689
+489
+245% +$9.67K ﹤0.01% 9198
2021
Q1 		$4K Buy
+200
New +$5.39K ﹤0.01% 8247

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Simplex Trading's BDTX Position: Q3 2025 in Review

Simplex Trading sold out of Black Diamond Therapeutics (BDTX) in Q3 2025, closing a stake of 2,186 shares — an estimated $6.39K sold.

Simplex Trading first reported a position in BDTX in Q1 2021 and held it in 12 quarters. The position peaked at $98K in Q2 2024. 91 funds tracked by Wall St. Rank hold BDTX as of Q3 2025.

  • Simplex Trading reported no remaining Black Diamond Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 2,186 Black Diamond Therapeutics shares in Q3 2025, an estimated $6.39K.
  • Simplex Trading first reported a position in Black Diamond Therapeutics in Q1 2021 and held it in 12 quarters.
  • Simplex Trading's Black Diamond Therapeutics position peaked at $98K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.